Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07203274

The Role of Janus Kinase (JAK) and Voltage-gated Sodium Channels (Nav) on Pain and Itch

The Role of Janus Kinase (JAK) and Voltage-gated Sodium Channels (Nav) on Pain and Itch Sensitivity in Healthy Volunteers

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Aalborg University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

It is well known that itch and pain have many communalities in terms of pathways and molecules involved. Therefore, it is very important to investi-gate different substances that work against both pain and itching. The substances delgocitinib and lidocaine have both been shown to relieve various types of pain. We therefore assume that these creams will be also able to relieve itching. The purpose of this trial experiment is therefore to investigate the effect of delgocitinib, lidocaine and their combination on experimentally induced itching.

Conditions

Interventions

TypeNameDescription
DRUGDelgocitinib creamDelgocitinib cream
DRUGlidocaine creamLidocaine cream
COMBINATION_PRODUCTLidocaine+DelgocitinibThe two cream will me mixed togheter
DRUGVehicle (placebo)Vehicle Cream
OTHERHistamine Dihydrochloride (HDC)One drop of histamine will be applied on the selected areas and pierced with a lancet
OTHERCowhage (Mucuna Pruriens)About 30 spicules will be applied on the selected areas and inserted manually

Timeline

Start date
2025-12-01
Primary completion
2025-12-31
Completion
2026-12-31
First posted
2025-10-02
Last updated
2025-11-21

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT07203274. Inclusion in this directory is not an endorsement.